Trial
NCT03381859
Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4
Phase IVWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Maryland, Baltimore
Collaborators
Merck Sharp & Dohme LLC; Cairo University
Condition
Hepatitis C Virus Infection, Response to Therapy of
Intervention
Elbasvir/Grazoprevir 50 MG-100 MG Oral Tablet [ZEPATIER]
Why stopped
HCV treatment expansion occurred in Egypt
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-04-20